Motor Neurone Disease Trial, Recruiting NCT07612371 Sponsor: Bahçeşehir University Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT07612371
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Be between 7 and 16 years old
  • Have been diagnosed with cerebral palsy that affects one side of the body, confirmed by a children's brain specialist
  • Be able to walk and move at a fairly independent level (levels I or II on a standard movement ability scale used by doctors)
  • Score above 24 on a standard thinking and understanding test designed for children
  • Have no cognitive (thinking or learning) difficulties that would prevent following simple task instructions
  • Both the child and their family are willing to take part in the study
  • Have a moderate to good level of hand and arm function (levels I to III on a standard hand use scale)
  • Be able to communicate at a functional level (levels I to III on a standard communication scale)

Who may not be able to join:

  • Children who have seizures that are not well controlled by medication
  • Children who have received specific brain-based movement training (motor imagery training or action observation therapy) in the last 6 months
  • Children who have tightness or stiffness in their muscles or joints that limits movement (contractures)
  • Children with serious problems with their vision or hearing
  • Children who have a lower level of independent movement ability (levels III, IV, or V on the standard movement scale)
  • Children who score below 24 on the standard children's thinking and understanding test
  • Children with lower hand and arm function ability (levels IV or V on the standard hand use scale)
  • Children who have had bone or joint surgery, or Botox injections for muscle stiffness, within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hasan K. Alptekin, Prof. Dr., Bahçeşehir University

Phone: +905314070105

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bahçeşehir University
Registry
ClinicalTrials.gov
Start date
15 May 2026
Est. completion
1 October 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

ABILHAND-Kids

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov